Volta
SARS-CoV-2 antigen rapid tests and universal screening for COVID-19 Omicron variant among hospitalized children
Unknown authors
· 2022
hash_id: ee78ad470046e82a89efd970c7f17d9f500ccddcc4f154914ae0395ecfe6d37d
· DOI: 10.1016/j.ajic.2022.11.002
Reference & gravity metrics
Citations
0
Citations / yr
0.00
RCR
Mass
0.00
Depth
0.00
Momentum
0.000
Burn rate
0.00 ATP/day
Start price
25.00 ATP
Secondary-market trade history
No secondary-market trades recorded for this Volta yet.
References (0)
No outbound references recorded.
Cited by (1)
| Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An up… | secondary |